Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
Saved in:
| Published in: | Current Obesity Reports |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301675800199168 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Current Obesity Reports |
| description | |
| discipline_display | Physical Medicine and Rehabilitation |
| discipline_facet | Physical Medicine and Rehabilitation |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:59846 |
| institution | FRELIP |
| journal_source_facet | Current Obesity Reports |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation Physical Medicine and Rehabilitation General Physical Medicine and Rehabilitation |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Physical Medicine and Rehabilitation General Physical Medicine and Rehabilitation Physical Medicine and Rehabilitation General Physical Medicine and Rehabilitation |
| subject_facet | Physical Medicine and Rehabilitation General Physical Medicine and Rehabilitation |
| title | The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation |
| title_auth | The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation |
| title_full | The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation |
| title_fullStr | The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation |
| title_full_unstemmed | The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation |
| title_short | The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation |
| title_sort | the role of glp1 receptor agonists and multi-agonist incretin therapies for specific obesity-related health conditions: evidence and rationale for prioritisation |
| topic | Physical Medicine and Rehabilitation General Physical Medicine and Rehabilitation |
| url | https://link.springer.com/article/10.1007/s13679-026-00707-6 |